Have a personal or library account? Click to login
Preoperative radiotherapy for rectal cancer: a comparative study of quality control adherence at two cancer hospitals in Spain and Poland Cover

Preoperative radiotherapy for rectal cancer: a comparative study of quality control adherence at two cancer hospitals in Spain and Poland

Radiology and Oncology
Volume 48 (2014): Issue 2 (June 2014)
By: Magdalena Fundowicz,  Miguel Macia,  Susanna Marin,  Marta Bogusz-Czerniewicz,  Ewelina Konstanty,  Ignaci Modolel,  Julian Malicki and  Ferran Guedea  
Open Access
|Apr 2014

References

  1. 1. Smith TJ, Hillner BE. Ensuring quality cancer care by the use of clinical practice guidelines and critical pathways. J Clin Oncol 2001; 19: 2886-97.10.1200/JCO.2001.19.11.2886
    Search in Google Scholar
  2. 2. Shortt K, Davidsson L, Hendry J, Dondi M, Andreo P. International perspectives on quality assurance and new techniques in radiation medicine: outcomes of an IAEA conference. Int J Radiat Oncol Biol Phys 2008; 71: S80-4.10.1016/j.ijrobp.2007.07.2390
    Search in Google Scholar
  3. 3. Cerezo L, Ciria JP, Arbea L, Linan O, Cafiero S, Valentini V, et al. Current treatment of rectal cancer adapted to the individual patient. Rep Pract Oncol Radiother 2013; 18: 353-62.10.1016/j.rpor.2013.08.005
    Search in Google Scholar
  4. 4. Cionini L, Gardani G, Gabriele P, Magri S, Morosini PL, Rosi A, et al. Quality indicators in radiotherapy. Radiother Oncol 2007; 82: 191-200.10.1016/j.radonc.2006.12.009
    Search in Google Scholar
  5. 5. Working Group “Assicurazione di Qualità in Radioterapia” of the Istituto Superiore di Sanità, editor. [Indications for quality assurance in conformal radiotherapy in Italy]. [Italian]. Rapporti ISTISAN 04/34. 2004. p. 54.
    Search in Google Scholar
  6. 6. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010; 46: 765-81.10.1016/j.ejca.2009.12.014
    Search in Google Scholar
  7. 7. Malicki J, Litoborski M, Bogusz-Czerniewicz M, Swiezewski A. Costeffectiveness of the modifications in the quality assurance system in radiotherapy in the example of in-vivo dosimetry. Phys Med 2009; 25: 201-6.10.1016/j.ejmp.2009.02.001
    Search in Google Scholar
  8. 8. Mainz J. Defining and classifying clinical indicators for quality improvement. Int J Qual Health Care 2003; 15: 523-30.10.1093/intqhc/mzg081
    Search in Google Scholar
  9. 9. Engstrom PF, Arnoletti JP, Benson AB 3rd, Chen Y-J, Choti MA, Cooper HS, et al. NCCN Clinical Practice Guidelines in Oncology: rectal cancer. J Natl Compr Canc Netw 2009; 7: 838-81.10.6004/jnccn.2009.0057
    Search in Google Scholar
  10. 10. Fortin A, Bairati I, Albert M, Moore L, Allard J, Couture C. Effect of treatment delay on outcome of patients with early-stage head-and-neck carcinoma receiving radical radiotherapy. Int J Radiat Oncol Biol Phys 2002; 52: 929-36.10.1016/S0360-3016(01)02606-2
    Search in Google Scholar
  11. 11. Chen Z, King W, Pearcey R, Kerba M, Mackillop WJ. The relationship between waiting time for radiotherapy and clinical outcomes: a systematic review of the literature. Radiother Oncol 2008; 87: 3-16.10.1016/j.radonc.2007.11.01618160158
    Search in Google Scholar
  12. 12. Korsgaard M, Pedersen L, Laurberg S. Delay of diagnosis and treatment of colorectal cancer: a population-based Danish study. Cancer Detect Prev 2008; 32: 45-51.10.1016/j.cdp.2008.01.001
    Search in Google Scholar
  13. 13. Duff SE, Wood C, McCredie V, Levine E, Saunders MP, O’Dwyer ST. Waiting times for treatment of rectal cancer in North West England. J R Soc Med 2004; 97: 117-8.10.1177/014107680409700304
    Search in Google Scholar
  14. 14. Fesinmeyer MD, Mehta V, Blough D, Tock L, Ramsey SD. Effect of radiotherapy interruptions on survival in medicare enrollees with local and regional head-and-neck cancer. Int J Radiat Oncol Biol Phys 2010; 78: 675-81.10.1016/j.ijrobp.2009.08.004
    Search in Google Scholar
  15. 15. Bese NS, Hendry J, Jeremic B. Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. Int J Radiat Oncol Biol Phys 2007; 68: 654-61.10.1016/j.ijrobp.2007.03.010
    Search in Google Scholar
  16. 16. Conde S, Borrego M, Teixeira T, Teixeira R, Sa A, Soares P. Neoadjuvant oral vs. infusional chemoradiotherapy on locally advanced rectal cancer: prognostic factors. Rep Pract Oncol Radiother 2013; 18: 67-75.10.1016/j.rpor.2012.07.010
    Search in Google Scholar
  17. 17. Tremblay D, Roberge D, Cazale L, Touati N, Maunsell E, Latreille J, et al. Evaluation of the impact of interdisciplinarity in cancer care. BMC Health Serv Res 2011; 11: 144.10.1186/1472-6963-11-144
    Search in Google Scholar
  18. 18. Jones WE 3rd, Thomas CR Jr, Herman JM, Abdel-Wahab M, Azad N, Blackstock W, et al. ACR appropriateness criteria: resectable rectal cancer. Radiat Oncol 2012; 7: 161.10.1186/1748-717X-7-161
    Search in Google Scholar
  19. 19. Mihaylova I, Parvanova V, Velikova C, Kurteva G, Ivanova D. Degree of tumor regression after preoperative chemo-radiotherapy in locally advanced rectal cancer-Preliminary results. Rep Pract Oncol Radiother 2011, 16: 233-8.10.1016/j.rpor.2011.06.008
    Search in Google Scholar
  20. 20. Molinari C, Ballardini M, Teodorani N, Giannini M, Zoli W, et al. Genomic alterations in rectal cancer tumors and response to neoadjuvant chemioradiotherapy; an exploratory study. Radiat Oncol 2011; 6: 161.10.1186/1748-717X-6-161
    Search in Google Scholar
  21. 21. Bogusz-Osawa M, Osawa T. The influence of the European and Polish acts of law, regulations and standards on the forms and the contents of the informed consent for oncological treatments. Rep Pract Oncol Radiother 2005; 10: 1-10.10.1016/S1507-1367(05)71111-1
    Search in Google Scholar
  22. 22. Byrne DJ, Napier A, Cuschieri A. How informed is signed consent? Br Med J (Clin Res Ed) 1988; 296: 839-40.
    Search in Google Scholar
  23. 23. Malicki J. The importance of accurate treatment planning, delivery, and dose verification. Rep Pract Oncol Radiother 2012; 17: 63-5.10.1016/j.rpor.2012.02.001386326124377001
    Search in Google Scholar
  24. 24. Richetti A, Fogliatta A, Clivo A, Nicolin G, Pesce G, et al. Neo-adjuvant chemo-radiation of rectal cancer with volumetric modulated arc therapy: summary of technical and dosimetric features and early clinical experience. Radiat Oncol 2010; 5: 14.10.1186/1748-717X-5-14283892020170490
    Search in Google Scholar
  25. 25. Saminathan S, Chandraraj S, Sridhar CH, Manickam R. Comparison of individual and composite field analysis using array detector for Intensity Mosulated Radiotherapy dose verification. Rep Pract Oncol Radiother 2012; 17: 157-62.10.1016/j.rpor.2012.03.004386324924377018
    Search in Google Scholar
  26. 26. Edwards CR, Mountford PJ. Characteristics of in vivo radiotherapy dosimetry. Br J Radiol 2009; 82: 881-3.10.1259/bjr/3256377719752169
    Search in Google Scholar
  27. 27. Edwards CR, Hamer E, Mountford PJ, Moloney AJ. An update survey of UK in vivo radiotherapy dosimetry practice. Br J Radiol 2007; 80: 1011-4.10.1259/bjr/1494515617967849
    Search in Google Scholar
  28. 28. Williams MV, McKenzie A. Can we afford not to implement in vivo dosimetry? Br J Radiol 2008; 81: 681-4.
    Search in Google Scholar
  29. 29. The Royal College of Radiologists. Towards safer radiotherapy. BFCO(08). London: Royal College of Radiologists; 2008. Available from: https://www.rcr.ac.uk/docs/oncology/pdf/Towards_saferRT_final.pdf.
    Search in Google Scholar
  30. 30. Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Potential benefits, limitations, and harms of clinical guidelines. BMJ 1999; 318: 527-30.10.1136/bmj.318.7182.527111497310024268
    Search in Google Scholar
  31. 31. Guedea F, Malicki J. Quality indicators in radiation oncology: in regard to Albert and Das. Int J Radiat Oncol Biol Phys 2013; 87: 432.10.1016/j.ijrobp.2013.06.206024074912
    Search in Google Scholar
  32. 32. Ishikura S. Quality assurance of radiotherapy in cancer treatment: toward improvement of patient safety and quality of care. Jpn J Clin Oncol 2008; 38: 723-9.10.1093/jjco/hyn11218952706
    Search in Google Scholar
  33. 33. Savatta SG, Temple L. Quality of life in patients treated for curable rectal cancer. Semin Colon Rectal Surg 2005; 16: 170-80.10.1053/j.scrs.2005.09.009
    Search in Google Scholar
  34. 34. International Atomic Energy Agency. International basic safety standards for protection against ionizing radiation and for the safety of radiation sources. IAEA Safety Series No. 115. Vienna: IAEA; 1996.
    Search in Google Scholar
  35. 35. Di Genesio Paglica M, Turri L, Munoz F, Melano A, Bacigalupo A, Franzone P, et al. Patterns of practice in the radiation therapy management of rectal cáncer: survey of the Interregional Group Piedmont, Valle d’Aosta and Liguria of the “Associazione Italiana di Radioterapia Oncologica (AIRO). Tumori 2013; 99: 61-7. 10.1177/030089161309900111
    Search in Google Scholar
DOI: https://doi.org/10.2478/raon-2014-0008 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 210 - 218
Submitted on: Nov 18, 2013
Accepted on: Feb 14, 2014
Published on: Apr 25, 2014
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
clinical audit,
quality control,
preoperative radiotherapy
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2014 Magdalena Fundowicz, Miguel Macia, Susanna Marin, Marta Bogusz-Czerniewicz, Ewelina Konstanty, Ignaci Modolel, Julian Malicki, Ferran Guedea, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 48 (2014): Issue 2 (June 2014)